Clarma Capital

Clarma Capital is a venture investor backing seed and early-stage life sciences companies in Europe and the United States. Its investment focus is on regulated products - medical devices, medicinal products and diagnostics - with a stated preference for ventures grounded in strong scientific principles, meaningful addressable markets, commercially minded management teams and clearly defined exit plans. The firm's geographic presence spans London, Switzerland, Dublin and Central Europe.

Alongside equity investment, the firm supports portfolio companies through follow-on fundraising, strategic partnerships, operational efficiency and business development, as well as guidance on regulatory challenges including FDA approvals and compliance. Regulatory affairs is one of the firm's core technical domains, alongside life sciences, medical devices, medicinal products and diagnostics.

Clarma Capital also works with incubators, innovation hubs, academic institutions, hospitals and other life sciences organisations to identify ventures and advance healthcare innovation. The firm describes its investment approach as anchored in ESG values and its engagement with portfolio companies and ecosystem partners as hands-on and collaborative.